As of January 23, 2025, BioXcel Therapeutics (BTAI) has a market cap of $18.040 million USD. According to our data, BioXcel Therapeutics is ranked No.8647 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 23, 2025 | $18.04 M |
-2.81%
|
Dec 31, 2024 | $18.56 M |
-87.32%
|
Dec 29, 2023 | $0.15 B |
-86.27%
|
Dec 30, 2022 | $1.07 B |
5.66%
|
Dec 31, 2021 | $1.01 B |
-56.00%
|
Dec 31, 2020 | $2.29 B |
216.22%
|
Dec 31, 2019 | $0.73 B |
278.50%
|
Dec 31, 2018 | $0.19 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
ACADIA Pharmaceuticals
ACAD
|
$2.96 B |
-0.000 M
|
USA
|
Intra-Cellular Therapies
ITCI
|
$13.51 B |
-0.000 M
|
USA
|
Sage Therapeutics
SAGE
|
$0.43 B |
-0.000 M
|
USA
|
Axsome Therapeutics
AXSM
|
$4.96 B |
0.000 M
|
USA
|
Alkermes
ALKS
|
$4.89 B |
-0.000 M
|
Ireland
|
Neurocrine Biosciences
NBIX
|
$14.86 B |
-0.000 M
|
USA
|
Otsuka Holdings
4578.T
|
$27.31 B |
-0.179 B
|
Japan
|
Eli Lilly
LLY
|
$678.07 B |
0.022 M
|
USA
|
Johnson & Johnson
JNJ
|
$349.75 B |
0.001 M
|
USA
|
Pfizer
PFE
|
$147.40 B |
-0.003 M
|
USA
|
AstraZeneca
AZN
|
$211.49 B |
0.007 M
|
UK
|
Bristol-Myers Squibb
BMY
|
$115.79 B |
-0.003 M
|
USA
|
Market Cap | = | BTAI Stock Price | * | BTAI Shares Outstanding |
= | $0.36 | * | 49.63 M | |
= | $18.04 M |